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A novel diperoxovanadate complex NH4[OV(O2)2{2-(2
0-pyridyl)-imidazole}] Æ 4H2O was synthesized in aqueous solution under
physiological conditions. The solution structure of the complex was characterized by multinuclear (1H, 13C, 14N, and 51V) as well as
multi-dimensional (DOSY and C-H COSY) NMR techniques in the interaction system of NH4VO3/H2O2/2-(2
0-pyridyl)-imidazole
at room temperature. The crystal structure of the complex was determined at 173 K by single-crystal X-ray diffraction method. It
belongs to the monoclinic space group P21/c with a = 13.048(4), b = 6.984(2), c = 17.814(5) Å, b = 104.695(5), V = 1570.3(8) Å3
and Z = 4. The crystal is composed of ammonium ions, {2-(2 0-pyridyl)-imidazole}oxodiperoxovanadate(V) ions, and water mole-
cules, which are held together by ionic and hydrogen bond forces. The metal atom in the complex is seven-coordinated with a dis-
torted pentagonal bipyramidal geometry. It is the first mononuclear diperoxovanadate complex with a N, N 0-chelating
biheteroaromatic ligand and its 51V chemical shift is at the highest field among the known mononuclear diperoxovanadate(V)
complexes.
 2005 Elsevier Inc. All rights reserved.
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Vanadate compounds were reported to be a new kind
of powerful insulin mimic and anticancer agents based
on their biological response both in vitro and in vivo
and may be developed into new oral drugs for diabetes
and tumor [1–10]. It is therefore not surprising to see
that coordination chemistry and biological mechanism
of vanadate compounds have recently encouraged many
interests [9–22]. For example, Orvig et al. have synthe-
sized and characterized many vanadium (III,IV,V)
complexes and studied their insulinomimetic activities
[18–24]. After the pioneer work of Orvig and co-workers,0162-0134/$ - see front matter  2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.jinorgbio.2005.06.007
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[7,8] using different ligands. Abu-Omar et al. [9,10] have
studied the kinetics and mechanisms of ligand substitu-
tion reactions of bisperoxovanadium(V) compounds at
physiological pH and the relevance to their DNA-cleav-
age activities. Kiss et al. [11–13] have characterized the
vanadium (IV,V) complexes in aqueous solution by sev-
eral spectroscopies. Pratt et al. [14–16] have investigated
the formation and structure of complexes between
hydroxamic acids and vanadate at neutral pH and their
mechanism of inhibition of the b-lactamase. Among
these studies, detailed and thorough spectroscopic inves-
tigations on the interaction systems between peroxo-
vanadate complexes and organic ligands have been
performed [25–30]. Several diperoxovanadate com-
plexes, such as Mn[OV(O2)2L] Æ mH2O (where M =
NH4
+, K+, Na+; n = 1–3; m = 1–5; L = ligand with C2
1946 X.-Y. Yu et al. / Journal of Inorganic Biochemistry 99 (2005) 1945–1951symmetry, for examples: 2,2 0-bipyridine, 1,10-phenan-
throline, 4,7-dimethyl-1,10-phenanthroline, and 3,4,7,8-
tetramethyl-1,10-phenanthroline), have been synthe-
sized [37]. It is found that pyridine (abbr. Py) is one kind
of important building blocks for peroxovanadate
compounds [37] and imidazole (abbr. Imi) has strong
coordinative ability [26,28,30,32,35]. Therefore, 2-(2 0-
pyridyl)-imidazole [abbr. 2-(2 0-Py)-Imi], which has both
the pyridine and imidazole group, is expected to be a
good ligand for formation of peroxovanadate coordina-
tion compounds. Based on this consideration, a new
peroxovanadate complex NH4[OV(O2)2{2-(2
0-Py)-
Imi}] Æ 4H2O was synthesized through the interaction
system of NH4VO3/H2O2/2-(2
0-Py)-Imi in aqueous solu-
tion under physiological conditions. Its structure was
characterized by solution NMR and single-crystal X-
ray diffraction. The structure and spectroscopic proper-
ties of the diperoxovanadate species in solution were
studied by 2D NMR diffusion ordered spectroscopy
(abbr. DOSY) as well as by 1D 1H, 13C, 14N, and 51V
NMR. Through the combination use of these methods,
a better understanding of the species was achieved. It is
the first mononuclear diperoxovanadate complex with a
N,N 0-chelating biheteroaromatic ligand and its 51V
chemical shift is at highest field among the known
mononuclear diperoxovanadate complexes in the
literature.2. Experimental
2.1. Materials and preparation
The compounds NH4VO3, H2O2, D2O, NaCl, Py,
and Imi were analytic grade reagents. 2-(2 0-Py)-Imi
shown in Fig. 1 was synthesized according to the litera-
ture [38]. To form the ternary system of NH4VO3/H2O2/
L (where L = Py, Imi, and 2-(2 0-Py)-Imi), NH4VO3 and




bpV), then L was added to the solution. The ionic med-
ium was chosen to represent physiological conditions,
0.15 mol/L NaCl D2O solution at 298 K in all NMR
measurements.
The diperoxovanadate complex was prepared by add-
ing 10 mL H2O2 (30%, w/v, solution) and 1.16 g
NH4VO3 (10 mmol) to 50 mL distilled water. After the
NH4VO3 was dissolved, 1.46 g 2-(2
0-Py)-Imi (10 mmol)
was added to the mixture. The mixture was stirred inN N
H
N
Fig. 1. Structure of 2-(2 0-pyridyl)-imidazole.cooled ice water bath at 273 K for 2 h. After that, etha-
nol was added gradually until a precipitate appeared.
The reaction mixture was then filtered and the solution
was kept at 283 K for a week to crystallize. The crystals
were filtered and washed with 2 mL cold water and 7 mL
cold ethanol (three times) and then dried on a filter pa-
per. The isolated yield was 73% based on the vanadate.
Anal. Calcd. for NH4[OV(O2)2(C8H7N3)] Æ 4H2O
(C8H19N4O9V): C, 26.24%; H, 5.23%; N, 15.30%.
Found: C, 26.11%; H, 5.05%; N, 15.41%. IR (KBr):
v = 3498 vs (>N–H), 3195 vs, 2916 vs, 2757 vs (H3N
+–
H), 1654 m, 1477 s, 1453 m, 1401 m, 1291 w, 1159 m,
974 m, 940 s (V@O), 923 m, 882 m (O–O)peroxo, 863 s
(O–O)peroxo, 790 m, 750 m, 707 m, 627 m (V–Operoxo),
588 s (V–Operoxo) cm
1. Raman: v = 974 s (V=O), 884
s (O–O)peroxo, 632 m (V–Operoxo), 588 m (V–Operoxo),
494 vs (V–Operoxo) cm
1. 1H NMR (D2O): 7.26 (t,
J = 5.9 Hz, 1H), 7.47 (s, 1H), 7.67 (d, J = 7.7 Hz, 1H),
7.75 (s, 1H), 7.82 (t, J = 7.7 Hz, 1H), 8.05 (s,
1H) ppm; 13C NMR (D2O): 149.0, 147.4, 145.1, 141.1,
132.9, 127.0, 123.9, 121.2 ppm.
2.2. Spectroscopy
All NMR spectra were recorded on Varian Unity
plus 500 spectrometer operating at 500.4 MHz for 1H,
125.7 MHz for 13C, 36.12 MHz for 14N, and
131.4 MHz for 51V NMR. The solvent for 1H, 13C,
14N, and 51V spectra was D2O. DSS [3-(trimethylsilyl)-
propanesulfonic acid sodium salt] was used as an inter-
nal reference for 1H and 13C chemical shifts. 14N and 51V
chemical shifts were measured relatively to the external
standard MeNO2 and VOCl3, respectively, with upfield
shifts considered negative. Signal-to-noise ratios were
improved by a line-broadening factor of 2, 50, or
10 Hz in the Fourier transformation of all 13C, 14N, or
51V spectra, respectively. DOSY was recorded using a
z-gradient probe, which delivered a maximum gradient
strength of 30 G/cm. The DOSY gradient compensated
stimulated echo spin lock (DGCSTESL) sequence [39]
was used for acquiring DOSY spectra. The typical
experimental parameters for a DOSY spectrum were
as follows: gradient duration d = 3 ms, gradient strength
G = 3 G/cm, spin lock time sSL = 1.5 ms, and time inter-
val s = 3.3 ms. Diffusion coefficient in NMR was gener-
ally achieved by stepwise ramping up of the amplitudes
of pulsed field gradients (PFGs), and the diffusion times
were optimized for every experiment. The typical time
required for a DOSY spectrum was approximately
0.8 h (16 scans, relaxation delay 4 s). Reference decon-
volution and baseline correction were used to compen-
sate experimental imperfections for all DOSY spectra.
Raman spectrum of the title complex in aqueous
solution was recorded on Labram I confocal microprobe
Raman system (Dilor, France). The excitation line is
632.8 nm from a He–Ne laser.
Table 1













Cell volume (Å3) 1570.3(8)
Z 4
Calculated density (g cm3) 1.549
Absorption coefficient (mm1) 0.681
F(000) 760
Crystal size (mm) 0.19 · 0.10 · 0.50
h Range for data collection () 2.36–25.00
Limiting indices 12 6 h 6 15,8 6 k 6 8,
20 6 l 6 21
Reflections collected/unique [Rint] 6914/2608 [0.0399]
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 2608/13/213
Goodness-of-fit on F2 1.135
Final R indices [I > 2r (I0)] R1 = 0.0532, wR2 = 0.1201
R indices (all data) R1 = 0.0632, wR2 = 0.1242
Largest diff. peak and hole (e Å3) 0.596 and 0.421
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Determination of the unit cell and data collection for
diperoxovanadate compound was performed on a Bru-
ker SMART CCD diffractometer at 173 K. Crystal data
and details of the data collection and refinement are col-
lected in Table 1. The structure was solved using direct
method implemented in the program SHELXS97. All
non-hydrogen atoms were refined using full-matrix
least-square procedure on F2. Anisotropic displacement
parameters were assigned to non-hydrogen atoms.Fig. 2. 51V spectra of the interaction system of NH4VO3/H2O2/2-(2
-
Py)-Imi in aqueous solution with 0.2 mol/L the total concentration of
vanadate species. From (a) to (f), the molar ratios of NH4VO3/H2O2/
2-(2 0-Py)-Imi are 1:5:0, 1:5:0.25, 1:5:0.5, 1:5:0.75, 1:5:1, and 1:5:2 with
pH values 3.5, 4.2, 4.5, 5.0, 6.7, and 7.6, respectively. The bpV refers to
the species [OV(O2)2(H2O)]
/[OV(O2)2(D2O)]
.3. Results and discussion
3.1. 51V and 14N NMR studies
In the mixture of NH4VO3 and H2O2with 1:5 molar
ratio (0.2 mol/L vanadate concentration), the 51V
NMR spectrum had a strong peak locating at
692 ppm, which was assigned to [OV(O2)2(D2O)]/
[OV(O2)2(H2O)]
 according to the previous reports
[30–36,40–42]. When 0.25, 0.5, 0.75, 1.0, or 2.0 equiva-
lent of 2-(2 0-Py)-Imi was added to the solution, respec-
tively, a new single peak appeared at about 784 ppm,
which was assigned to a new species [OV(O2)2{2-(2
0-
Py)-Imi}]. To the best of our knowledge, its chemical
shift is at the highest field among the known mononu-
clear diperoxovanadate(V) compounds. The intensity
of the new peak increased with the increasing of thequantity of ligand added before reaching a maximum,
as shown in Fig. 2. When the equivalent of 2-(2 0-Py)-
Imi reached 1.0, almost all [OV(O2)2(D2O)]
/
[OV(O2)2(H2O)]
 converted into the new species. In
the meantime, a tiny peak at 732 ppm was found
which was assigned to VðO2Þ3 [43] (see Fig. 2(e)).
Generally, the chemical shift of the species
[OV(O2)2(D2O)]
/[OV(O2)2(H2O)]
 will change a little
bit when the solution pH value changes [31,32]. How-
ever, Fig. 2 shows that the chemical shift of
[OV(O2)2(D2O)]
/[OV(O2)2(H2O)]
 hardly changed in
this study.
As N atoms are involved in the reaction, 14N/15N
NMR spectrum may provide some useful information
on the interaction system. Since 15N has very low natural
abundance (0.37%) and the residual paramagnetism of
vanadium broadens the 15N peaks, the signal-to-noise
ratio of 15N spectra is too low to give useful information
for the interaction system. Therefore, only 14N NMR
shown in Fig. 3 was measured in this work. For the pure
2-(2 0-Py)-Imi solution, two 14N peaks appeared at about
295 and 195 ppm, respectively. For the interaction
system of NH4VO3/H2O2/2-(2
0-Py)-Imi with 1:5:1 molar
ratio (0.2 mol/L vanadate concentration), two 14N peaks
of the coordinated 2-(2 0-Py)-Imi appeared at about 219
and 157 ppm, which were much more shielded than the
free ligand.
To test the stability of the newly-formed species
[OV(O2)2{2-(2
0-Py)-Imi}], the 51V NMR spectra of
the interaction system were recorded every 24 h at
298 K. During the experimental period (7 days), the
51V peak was unchanged. It means that the new species
is rather stable and the spectra obtained from long time
Fig. 4. 13C spectra of the aqueous solution of (a) NH4VO3/H2O2/2-
(2 0-Py)-Imi with a molar ratio of 1:5:1 with pH 6.7, (b) NH4VO3/
H2O2/2-(2
0-Py)-Imi with a molar ratio of 1:5:2 with pH 7.6, and (c)
NH4[OV(O2)2{2-(2
0-Py)-Imi}] Æ 4H2O with pH 6.9. The total concen-
tration of vanadate species is 0.2 mol/L.
Fig. 3. 14N spectra of the aqueous solution of (a) 2-(2 0-Py)-Imi and (b)
the interaction system of NH4VO3/H2O2/2-(2
0 -Py)-Imi with a molar
ratio of 1:5:1 with pH 6.7 and total concentration of vanadate species
0.2 mol/L.
1948 X.-Y. Yu et al. / Journal of Inorganic Biochemistry 99 (2005) 1945–1951measurements such as 13C–1H COSY and 13C NMR
spectra are creditable.
3.2. 1H and 13C NMR spectra
The spectral data are listed in Table 2.
For the interaction system of NH4VO3/H2O2/2-(2
0-
Py)-Imi with 1:5:1 molar ratio (0.2 mol/L vanadate con-
centration), both 1H and 13C NMR spectra had only one
group of peaks (see Fig. 4(a) for 13C spectrum), implying
that 2-(2 0-Py)-Imi was almost coordinated to the central
vanadium atom and only one coordination way is pres-
ent. Increasing the molar ratio of NH4VO3/H2O2/2-(2
0-
Py)-Imi to 1:5:2, another group of 1H and13C peaks
appeared (see Fig. 4(b)), which was assigned to the free
ligand. Based on 14N NMR spectra shown in Fig. 3, it can
be concluded that at least one V–N bond was formed in
the interaction system. This nitrogen atom should be in
the imidazole ring since it is much easier to form V–N
bond than pyridine (see discussion in Section 3.5). When
imiazole ligand coordinates to diperoxovanadate form-
ing a six-coordinated complex, the 51V chemical shift
of vanadate is about 749 ppm, as reported by Petters-
son and Crans [17,26,28,32]. However, the 51V chemical
shift of the title complex locates at 784 ppm, which
moves to upfield 35 ppm compared with the six-coordi-
nated complex [OV(O2)2(Imi)]
. A similar situation can
be found in a seven-coordinated complex [OV(O2)2-Table 2
1H and 13C NMR spectral data of the interaction system of NH4VO3/H2O2
Species Chemical shifts (ppm)
1H
[OV(O2)2{2-(2
0-Py)-Imi}]b 7.24 (t, J = 5.9 Hz, 1H), 7.41 (s, 1H), 7.60 (d,
7.73 (s, 1H), 7.77 (t, J = 7.7 Hz, 1H), 8.05 (s, 1
[OV(O2)2{2-(2
0-Py)-Imi}]c 7.24 (t, J = 5.9 Hz, 1H), 7.41 (s, 1H), 7.56 (d,
7.76 (complex, 2H), 8.08 (s, 1H)
2-(20-Py)-Imic 7.22 (s, 2H), 7.35 (t, J = 5.5 Hz, 1H), 7.81 (com
7.85 (complex, 1H), 8.47 (d, J = 3.3 Hz, 1H)
a The ionic medium is 0.15 mol/L NaCl in D2O solution at 298 K. The to
b The molar ratio of NH4VO3/H2O2/2-(2
0-Py)-Imi is 1:5:1 with pH 6.7.
c The molar ratio of NH4VO3/H2O2/2-(2
0-Py)-Imi is 1:5:2 with pH 7.6.(bipy)] (51V NMR 746 ppm [26]). Compared with
the six-coordinated complex [OV(O2)2(Py)]
 (51V NMR
711 ppm [25]), the 51V chemical shift of [OV(O2)2-
(bipy)] moves to upfield 35 ppm since there are two
pyridine groups coordinating to metal center. Therefore,
according to the chemical shifts and the relative areas of
the 1H and 51V peaks, we deduced that the two N atoms
in the ligand were chelating to the central vanadium
atom. Since 2-(2 0-Py)-Imi is a N,N 0-chelating biheteroa-
romatic ligand, theoretically there are two possible ways
for it to coordinate to the vanadium atom (isomers A
and B as shown in Fig. 5) [44]. Why only one isomer
was observed in our experiments? Which isomer is it?
We will come to it in Section 3.5.
3.3. DOSY spectra
The DOSY spectrum of NH4VO3/H2O2/2-(2
0-Py)-
Imi (1:5:2, 0.2 mol/L vanadate concentration) in solu-
tion is shown in Fig. 6. Except for the solvent, there were
two components producing 1H peaks. The component
with slower diffusion rate marked by broken line was as-/2-(2 0-Py)-Imi in aqueous solutiona
13C
J = 7.7 Hz, 1H),
H)
149.0, 147.4, 145.1, 141.1, 132.9, 127.0, 123.0, 121.2
J = 7.7 Hz, 1H), 149.0, 147.4, 145.1, 141.1, 132.9, 126.9 123.0, 121.1
plex, 1H), 156.6, 149.2, 147.8, 140.7, 126.6, 126.3, 122.9















Isomer A Isomer B
–
–
Fig. 5. The possible isomers of [OV(O2)2{2-(2
0-Py)-Imi}].
Fig. 6. 2D 1H DOSY spectrum of the interaction system of NH4VO3/
H2O2/2-(2
0-Py)-Imi with a molar ratio of 1:5:2 with pH 7.6 in aqueous
solution. The total concentration of vanadate species is 0.2 mol/L. The
peaks from free ligand are marked by solid line and the peaks from the
newly-formed species [OV(O2)2{2-(2
0-Py)-Imi}] are marked by bro-
ken line.








V(1)–O(5) 1.614(2) O(1)–V(1)–O(2) 45.28(11)
V(1)–O(1) 1.879(2) O(1)–V(1)–O(3) 132.04(11)
V(1)–O(4) 1.891(2) O(1)–V(1)–O(4) 88.81(11)
V(1)–O(3) 1.899(2) O(1)–V(1)–O(5) 103.02(12)
V(1)–O(2) 1.918(2) O(1)–V(1)–N(1) 132.58(11)
V(1)–N(1) 2.102(3) O(1)–V(1)–N(2) 85.63(10)
V(1)–N(2) 2.356(3) O(2)–V(1)–O(3) 159.24(11)
O(1)–O(2) 1.462(3) O(2)–V(1)–N(1) 88.60(11)





X.-Y. Yu et al. / Journal of Inorganic Biochemistry 99 (2005) 1945–1951 1949signed to the newly-formed species, [OV(O2)2{2-(2
0-Py)-
Imi}]. Another component marked by solid lines was
assigned to the free ligand. The result of DOSY experi-
ments supports the spectroscopic assignments men-
tioned above.
3.4. Crystal structure
The crystal of NH4[OV(O2)2(C8H7N3)] Æ 4H2O con-
sists of ammonium ions, {2-(2 0-pyridyl)-imidaz-
ole}oxodiperoxovanadate(V) ions and water molecules.
They are held together by ionic and hydrogen bond
forces. The content of structure unit is shown in
Fig. 7. Bond distances and angles are given in Table 3.
The species, [OV(O2)2{2-(2
0-Py)-Imi}], has a distorted
pentagonal bipyramidal geometry, which is often ob-
served in transition metal peroxo complexes [1,45,46].
The vanadium atom displaces 0.341 Å from the equato-
rial plane (defined by O1, O2, O3, O4, and N1 within the
limits of experimental error) towards the vanadyl oxy-
gen atom, comparable to approximately 0.3 Å in se-
ven-coordinated diperoxovanadate complexes [47]. The
V–Operoxo bond lengths (1.881–1.918 Å) lie in the range
of the normal V–Operoxo bond distances reported previ-
ously [1,45–49]. The lengths of the (O–O)peroxo (1.449
and 1.462 Å), V@O (1.616 Å), V–Nequatorial (2.103 Å),
and V–Napical (2.360 Å) bonds are in good agreement
with the corresponding values reported for other per-
oxovanadate complexes [1,45–49]. The seven-coordi-nated manner of the vanadium atom verifies our
deduction based on NMR study. The chemical shifts
of the 1H and 13C NMR spectra of NH4[OV(O2)2(C8H7-
N3)] Æ 4H2O in aqueous solution are the same as those
measured from the interaction system of NH4VO3/
H2O2/2-(2
0-Py)-Imi within the limits of experimental
error (see Fig. 4 for 13C spectra. The very slight differ-
ence of chemical shifts is due to the difference of pH
value.), implying that both the [OV(O2)2{2-(2
0-Py)-
Imi}] from the interaction system and the dissolved
crystal has the same structure.
3.5. Interaction modes
As we have mentioned above, the coordination of 2-
(2 0-Py)-Imi to [VO(O2)2(H2O)]








Fig. 9. The equilibrium exists for 2-(2 0-Py)-Imi.
1950 X.-Y. Yu et al. / Journal of Inorganic Biochemistry 99 (2005) 1945–1951and B (Fig. 5). However, only one isomer was observed
in our experiments both in the solution and in crystal
state. The determination of crystal structure revealed
that the product was isomer A. Since the crystal was
crystallized from the solution, it is quite possible that
the complex has the same coordination manner in solu-
tion and in solid state, as reported in Raman study of
K2[VO(O2)2(C2O4)] Æ H2O and NH4[VO(O2)2NH3]
[50,51]. Combined with the conclusion from the 1H
and 13C NMR spectra of NH4[OV(O2)2(C8H7N3)] Æ 4-
H2O in aqueous solution and the interaction system of
NH4VO3/H2O2/2-(2
0-Py)-Imi, we conclude that the
structure of [OV(O2)2{2-(2
0-Py)-Imi}] formed in the
interaction system is the same as its crystal structure,
which is isomer A. In order to explain why only isomer
A was observed, another two interaction systems,
NH4VO3/H2O2/Imi and NH4VO3/H2O2/Py, which
have been studied systematically [25–28,30,32,35],
were used as references. The 51V chemical shifts of
[OV(O2)2(Imi)]
 and [OV(O2)2(Py)]
 are 749 and
711, respectively. Fig. 8 shows the most possible reac-
tion modes of the interaction systems of NH4VO3/
H2O2/Imi and NH4VO3/H2O2/Py. For NH4VO3/
H2O2/Imi system, imidazole attacks the vanadium atom
of [OV(O2)2(H2O)]
 and forms TS1. Accompanied by
the leaving of water, [OV(O2)2(Imi)]
 forms. When the
ligand is replaced by pyridine, it undergoes a similar
process and forms species [OV(O2)2(Py)]
. In the inter-
action system of NH4VO3/H2O2/Imi/Py (1:5:1:1 molar
ratio, 0.1 mol/L vanadate concentration), the molar ra-
tio between species [OV(O2)2(Imi)]
 and [OV(O2)2(Py)]

was determined to be 10:1 from the area ratio of their
51V peaks, implying the much stronger reactivity of
imidazole than pyridine. Therefore, for the bidentate li-
gand 2-(2 0-Py)-Imi, it would be much more possible that


























Fig. 8. The possible reaction modes of the two interactiondium first and forms TS1. Accompanied by the leaving
of water, the nitrogen atom in pyridine turns to apical
position and forms the second V–N bond. This results
in isomer A. In addition, an equilibrium exists in 2-(2 0-
Py)-Imi solution, shown in Fig. 9. Since 2-(2 0-Py)-Imi-
B has a hydrogen bond and is favorable in energy, it
is the dominant species. The domination of 2-(2 0-Py)-
Imi-B further increases the chance of coordination of
imidazole ring due to the existence of hydrogen bond
which blocks the coordination of pyridine ring. These
may be the reasons that only isomer A has been
observed.4. Conclusions
In this paper, the interaction system of NH4VO3/
H2O2/2-(2
0-Py)-Imi under physiological conditions was
studied by several NMR techniques. Strong interactions
between vanadium atom and 2-(2 0-Py)-Imi were ob-
served, indicating the effectiveness of ligands with aro-
matic nitrogen in the formation of diperoxovanadate
complexes. A new diperoxovanadate crystal was ob-
tained. The crystal structure was characterized by sin-
gle-crystal X-ray diffractometry. This is the first
mononuclear diperoxovanadate complex with a N,N 0-
chelating biheteroaromatic ligand and its 51V chemical
























systems, NH4VO3/H2O2/Imi and NH4VO3/H2O2/Py.
X.-Y. Yu et al. / Journal of Inorganic Biochemistry 99 (2005) 1945–1951 1951clear diperoxovanadate complexes reported in literature.
Further studies on its insulin-like activity are being car-
ried out.
Obviously, NMR experimental techniques provide a
powerful tool to explore the coordinative ways and solu-
tion structures of the interaction systems as well as to
monitor the formation of new complexes. These meth-
ods are being used for further study of the interaction
mechanisms between vanadium compounds and organic
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